NXU (NASDAQ:NXU – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.13) earnings per share (EPS) for the quarter, Zacks reports. NXU had a negative net margin of 5,280.30% and a negative return on equity of 219.40%. NXU Stock Performance Shares of NXU opened at $0.24 on Wednesday. NXU has […]

Bolt Projects (NASDAQ:BSLK – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.19) earnings per share (EPS) for the quarter, Zacks reports. Bolt Projects Stock Down 3.6 % Shares of Bolt Projects stock traded down $0.01 during trading hours on Tuesday, reaching $0.32. The company’s stock had a trading volume of […]

Trevi Therapeutics (NASDAQ:TRVI – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $12.50 target price on the stock. HC Wainwright’s target price indicates a potential upside of 90.55% from the company’s current […]

Trevi Therapeutics (NASDAQ:TRVI – Get Free Report) announced its earnings results on Tuesday. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.01, Zacks reports. Trevi Therapeutics Price Performance Shares of NASDAQ TRVI traded up $0.06 during midday trading on Tuesday, hitting $6.60. The company’s stock had […]

Harrow (NASDAQ:HROW – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $57.00 price objective on the stock. HC Wainwright’s target price indicates a potential upside of 115.11% from the company’s current price. Separately, B. Riley lowered their […]

Aterian (NASDAQ:ATER – Get Free Report) announced that its Board of Directors has authorized a stock repurchase plan on Tuesday, March 18th, RTT News reports. The company plans to repurchase $3.00 million in shares. This repurchase authorization authorizes the company to buy up to 16.2% of its shares through open market purchases. Shares repurchase plans […]

XOMA (NASDAQ:XOMA – Get Free Report) issued its earnings results on Monday. The biotechnology company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.29) by ($0.17), Zacks reports. The firm had revenue of $8.70 million during the quarter, compared to analyst estimates of $8.75 million. XOMA had a negative net […]

MiNK Therapeutics (NASDAQ:INKT – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a $35.00 target price on the stock. HC Wainwright’s price target indicates a potential upside of 336.41% from the stock’s current price. MiNK Therapeutics Stock […]

Aterian (NASDAQ:ATER – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.18) earnings per share for the quarter, topping the consensus estimate of ($0.58) by $0.40, Zacks reports. Aterian had a negative return on equity of 56.01% and a negative net margin of 17.05%. Aterian updated its FY 2025 guidance […]

Liquidia (NASDAQ:LQDA – Get Free Report) released its earnings results on Wednesday. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.39) by ($0.07), Zacks reports. Liquidia had a negative return on equity of 163.21% and a negative net margin of 765.38%. Liquidia Stock Performance NASDAQ:LQDA opened at […]

StoneCo (NASDAQ:STNE – Get Free Report) released its earnings results on Tuesday. The company reported $0.39 EPS for the quarter, topping the consensus estimate of $0.32 by $0.07, Zacks reports. StoneCo had a return on equity of 13.92% and a net margin of 16.02%. StoneCo Price Performance STNE stock traded down $0.34 on Tuesday, reaching […]

Xenetic Biosciences (NASDAQ:XBIO – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.68) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.48), Zacks reports. Xenetic Biosciences had a negative return on equity of 49.51% and a negative net margin of 161.63%. Xenetic Biosciences Stock […]

Aadi Bioscience (NASDAQ:AADI – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.67) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.31) by ($0.36), Zacks reports. Aadi Bioscience had a negative net margin of 246.06% and a negative return on equity of 71.87%. Aadi Bioscience Trading […]

Korro Bio (NASDAQ:KRRO – Get Free Report) announced its earnings results on Tuesday. The company reported ($2.26) earnings per share for the quarter, beating the consensus estimate of ($2.33) by $0.07, Zacks reports. The business had revenue of $2.27 million for the quarter. Korro Bio Stock Down 3.6 % Shares of KRRO stock opened at […]

Sangamo Therapeutics (NASDAQ:SGMO – Get Free Report) announced its earnings results on Monday. The biopharmaceutical company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by ($0.02), Zacks reports. Sangamo Therapeutics had a negative net margin of 257.87% and a negative return on equity of 264.16%. The company had […]